Biological activities and potential molecular targets of cucurbitacins: a focus on cancer
- PMID: 22561419
- DOI: 10.1097/CAD.0b013e3283541384
Biological activities and potential molecular targets of cucurbitacins: a focus on cancer
Abstract
Cucurbitacin and its derivatives (cucurbitacins) are a class of highly oxidized tetracyclic triterpenoids. They are widely distributed in the plant kingdom, where they act as heterologous chemical pheromones that protect plants from external biological insults. Their bioactivities first attracted attention in the 1960s. Documented data demonstrate that cucurbitacins possess strong pharmacological properties, such as antitumor, anti-inflammatory, and hepatoprotective effects, etc. Several molecular targets for cucurbitacins have been discovered, such as fibrous-actin, signal transducer and activator of transcription 3, cyclooxygenase-2, etc. The present study summarizes the achievements of the 50 years of research on cucurbitacins. The aim was to systematically analyze their bioactivities with an emphasis on their anticancer effects. Research and development has shed new insight into the beneficial properties of these compounds.
Similar articles
-
Cucurbitacins: A Systematic Review of the Phytochemistry and Anticancer Activity.Am J Chin Med. 2015;43(7):1331-50. doi: 10.1142/S0192415X15500755. Epub 2015 Oct 27. Am J Chin Med. 2015. PMID: 26503558
-
Cucurbitacin: ancient compound shedding new light on cancer treatment.ScientificWorldJournal. 2010 Mar 5;10:413-8. doi: 10.1100/tsw.2010.44. ScientificWorldJournal. 2010. PMID: 20209387 Free PMC article. Review.
-
Potential of cucurbitacin as an anticancer drug.Biomed Pharmacother. 2023 Dec;168:115707. doi: 10.1016/j.biopha.2023.115707. Epub 2023 Oct 18. Biomed Pharmacother. 2023. PMID: 37862969 Review.
-
Cucurbitacins as Anticancer Agents: A Patent Review.Recent Pat Anticancer Drug Discov. 2019;14(2):133-143. doi: 10.2174/1574892813666181119123035. Recent Pat Anticancer Drug Discov. 2019. PMID: 30451116 Review.
-
Recent Advances in the Application of Cucurbitacins as Anticancer Agents.Metabolites. 2023 Oct 14;13(10):1081. doi: 10.3390/metabo13101081. Metabolites. 2023. PMID: 37887406 Free PMC article. Review.
Cited by
-
Synthesis of Cucurbitacin B Derivatives as Potential Anti-Hepatocellular Carcinoma Agents.Molecules. 2018 Dec 18;23(12):3345. doi: 10.3390/molecules23123345. Molecules. 2018. PMID: 30567327 Free PMC article.
-
The Inhibition of Gastric Cancer Cells' Progression by 23,24-Dihydrocucurbitacin E through Disruption of the Ras/Raf/ERK/MMP9 Signaling Pathway.Molecules. 2022 Apr 22;27(9):2697. doi: 10.3390/molecules27092697. Molecules. 2022. PMID: 35566048 Free PMC article.
-
Comparative Analysis between Wild and Cultivated Cucumbers Reveals Transcriptional Changes during Domestication Process.Plants (Basel). 2020 Jan 3;9(1):63. doi: 10.3390/plants9010063. Plants (Basel). 2020. PMID: 31947725 Free PMC article.
-
Cucurbitacin E Suppresses Adipogenesis and Lipid Accumulation in 3T3-L1 Adipocytes Without Cytotoxicity.Biomedicines. 2025 Jul 25;13(8):1826. doi: 10.3390/biomedicines13081826. Biomedicines. 2025. PMID: 40868081 Free PMC article.
-
Modified mixed nanomicelles with collagen peptides enhanced oral absorption of Cucurbitacin B: preparation and evaluation.Drug Deliv. 2018 Jan 1;25(1):862-871. doi: 10.1080/10717544.2018.1425773. Drug Deliv. 2018. PMID: 29608116 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials